Carlson Douglas R

See Remarks

Carlson Douglas R has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Nov 19, 2026.

On the most recent filing, Carlson Douglas R is listed as See Remarks at Avalyn Pharma Inc. Inside the rolling window, Carlson Douglas R reported no open-market purchases and 1 open-market sale totaling $415K in AVLN.

Companies traded

Other insiders at AVLN

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$415K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
AVLNSale$415KNov 19SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Carlson Douglas R made?

Carlson Douglas R has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company since 2026.

Which companies does Carlson Douglas R trade?

Carlson Douglas R has filed SEC Form 4 disclosures for 1 company, including AVLN.

When was Carlson Douglas R's most recent SEC Form 4 filing?

Carlson Douglas R's most recent SEC Form 4 filing on Tracefour is dated Nov 19, 2026.

What is Carlson Douglas R's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Carlson Douglas R is listed as See Remarks.

What is Carlson Douglas R's total buy and sell value in the current window?

Inside the rolling retention window, Carlson Douglas R bought $0 and sold $415K based on SEC Form 4 filings.

What was Carlson Douglas R's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 14,875 AVLN shares on 2026-11-17, worth $415K, per SEC Form 4 filings.